SANA 10-Q: SEC filing
Sana Biotechnology
Filed with the SEC on · accession 0001193125-26-449836
SANA filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -8.6% by the first close after the filing.
Summary of the filing
Sana Biotechnology filed its quarterly 10-Q report for the period ending September 30, 2026, reporting 299,634,951 shares of common stock outstanding.
Key details
How SANA stock reacted
Close before
$2.56
Nov 4, 2026
First close after
-8.59%
$2.34
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for SANA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SANA?
Click hereFrequently asked questions
What did SANA file with the SEC on Nov 5, 2026?
SANA filed a 10-Q (SEC filing). Sana Biotechnology filed its quarterly 10-Q report for the period ending September 30, 2026, reporting 299,634,951 shares of common stock outstanding.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did SANA stock react to this filing?
SANA closed at $2.56 before the filing and $2.34 on Nov 5, 2026 (-8.59%).
Other SANA SEC filings
Get alerts when SANA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days